Retrospective identification of prenatal fetal anomalies associated with diagnostic neonatal genomic sequencing results.


Journal

Prenatal diagnosis
ISSN: 1097-0223
Titre abrégé: Prenat Diagn
Pays: England
ID NLM: 8106540

Informations de publication

Date de publication:
05 2022
Historique:
revised: 04 01 2022
received: 17 04 2021
accepted: 03 02 2022
pubmed: 11 2 2022
medline: 20 5 2022
entrez: 10 2 2022
Statut: ppublish

Résumé

To determine which types of fetal anomalies are associated with postnatal diagnoses of genetic diseases by genomic sequencing and to assess how prenatal genomic sequencing could affect clinical management. This was a secondary analysis of the second Newborn Sequencing in Genomic Medicine and Public Health study that compared fetal imaging results in critically ill infants who had actionable versus negative postnatal genomic sequencing results. Of 213 infants who received genomic sequencing, 80 had available prenatal ultrasounds. Twenty-one (26%) of these were found to have genetic diseases by genomic sequencing. Fourteen (67%) of the 21 with genetic diseases had suspected anomalies prenatally, compared with 33 (56%) of 59 with negative results. Among fetuses with suspected anomalies, genetic diseases were 4.5 times more common in those with multiple anomalies and 6.7 times more common in those with anomalies of the extremities compared to those with negative results. Had the genetic diseases been diagnosed prenatally, clinical management would have been altered in 13 of 14. Critically ill infants with diagnostic genomic sequencing were more likely to have multiple anomalies and anomalies of the extremities on fetal imaging. Among almost all infants with suspected fetal anomalies and diagnostic genomic sequencing results, prenatal diagnosis would have likely altered clinical management.

Identifiants

pubmed: 35141907
doi: 10.1002/pd.6111
pmc: PMC9886440
mid: NIHMS1863332
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

705-716

Subventions

Organisme : NICHD NIH HHS
ID : K12 HD105271
Pays : United States
Organisme : NICHD NIH HHS
ID : U19 HD077693
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR002550
Pays : United States
Organisme : National Institute of Child Health and Human Development
ID : U19HD077693

Informations de copyright

© 2022 John Wiley & Sons Ltd.

Références

J Med Genet. 2021 Jun;58(6):400-413
pubmed: 32732226
Lancet. 2019 Feb 23;393(10173):758-767
pubmed: 30712878
Ultrasound Q. 2008 Dec;24(4):215-23
pubmed: 19060688
Sci Transl Med. 2019 Apr 24;11(489):
pubmed: 31019026
Am J Obstet Gynecol. 2018 Jul;219(1):B2-B9
pubmed: 29705191
J Genet Couns. 2018 Sep;27(5):1130-1147
pubmed: 29516345
J Genet Couns. 2020 Dec;29(6):1221-1233
pubmed: 32453502
Obstet Gynecol Clin North Am. 2018 Mar;45(1):69-81
pubmed: 29428287
J Genet Couns. 2020 Dec;29(6):1159-1172
pubmed: 32302042
J Ultrasound Med. 2018 Nov;37(11):E13-E24
pubmed: 30308091
Genet Med. 2014 Jan;16(1):40-4
pubmed: 23765047
Genome Med. 2018 Sep 28;10(1):74
pubmed: 30266093
Genet Med. 2012 Feb;14(2):250-8
pubmed: 22241091
Am J Hum Genet. 2020 Nov 5;107(5):953-962
pubmed: 33157008
Genet Med. 2007 Sep;9(9):596-9
pubmed: 17873647
Ultrasound Obstet Gynecol. 2005 Aug;26(2):115-22
pubmed: 16038011
Eur J Pediatr. 2005 Mar;164(3):146-53
pubmed: 15565286
Am J Hum Genet. 2020 Nov 5;107(5):942-952
pubmed: 33157007
Lancet. 2019 Feb 23;393(10173):747-757
pubmed: 30712880
Hum Genet. 2018 Feb;137(2):175-181
pubmed: 29392406
Am J Hum Genet. 2019 Oct 3;105(4):719-733
pubmed: 31564432
Prenat Diagn. 2012 Oct;32(10):986-95
pubmed: 22847778
J Ultrasound Med. 2002 Jul;21(7):719-22; quiz 724-5
pubmed: 12099558
Eur J Hum Genet. 2019 Sep;27(9):1389-1397
pubmed: 31053788
N Engl J Med. 2020 Oct 29;383(18):1746-1756
pubmed: 33027564
Nucleic Acids Res. 2021 Jan 8;49(D1):D1207-D1217
pubmed: 33264411
Obstet Gynecol. 2020 Oct;136(4):e48-e69
pubmed: 32804883
Ultrasound Obstet Gynecol. 2018 Apr;51(4):493-502
pubmed: 28976722
J Ultrasound Med. 2001 Feb;20(2):141-4
pubmed: 11211134
Eur J Endocrinol. 2011 Aug;165(2):345-52
pubmed: 21606191

Auteurs

Kathy Zhang-Rutledge (K)

Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California San Diego, La Jolla, California, USA.

Mallory Owen (M)

Rady Children's Institute of Genomic Medicine, San Diego, California, USA.

Nathaly M Sweeney (NM)

Rady Children's Institute of Genomic Medicine, San Diego, California, USA.
Department of Pediatrics, University of California San Diego, La Jolla, California, USA.

David Dimmock (D)

Rady Children's Institute of Genomic Medicine, San Diego, California, USA.

Stephen F Kingsmore (SF)

Rady Children's Institute of Genomic Medicine, San Diego, California, USA.

Louise C Laurent (LC)

Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California San Diego, La Jolla, California, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH